UK markets closed

Novacyt S.A. (NCYT.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
1,084.00+38.00 (+3.63%)
At close: 4:30PM GMT
Full screen
Previous close1,046.00
Open1,072.00
Bid1,080.00 x 0
Ask1,088.00 x 0
Day's range1,058.00 - 1,116.00
52-week range13.15 - 1,276.00
Volume513,193
Avg. volume1,113,842
Market cap772.159M
Beta (5Y monthly)-3.03
PE ratio (TTM)N/A
EPS (TTM)-26.20
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Novacyt shares: insiders are buying. Should I buy too?
    Fool.co.uk

    Novacyt shares: insiders are buying. Should I buy too?

    Since Novacyt shares have pulled back, a number of top-level directors have purchased stock. This suggests these insiders are confident, but am I? The post Novacyt shares: insiders are buying. Should I buy too? appeared first on The Motley Fool UK.

  • Investment platform sees 'record-breaking day' following COVID-19 vaccine breakthrough
    Yahoo Finance UK

    Investment platform sees 'record-breaking day' following COVID-19 vaccine breakthrough

    The UK’s second largest direct-to-consumer investment platform, interactive investor, said it experienced a “record-breaking” day on Monday after news of Pfizer’s COVID-19 vaccine breakthrough sent markets on a tear, the company said in a statement on Tuesday.

  • Novacyt launches test to differentiate COVID-19 and flu
    Reuters

    Novacyt launches test to differentiate COVID-19 and flu

    Clinical diagnostics company Novacyt, one of many healthcare companies whose shares have surged during the pandemic, launched a test on Thursday to differentiate between COVID-19 and common winter diseases. Novacyt said its "Winterplex" test panel included two gene targets specific to COVID-19, as well as gene targets for influenza A&B and respiratory syncytial virus (RSV). "We believe Winterplex™ is one of the world’s first approved respiratory test panels that can differentiate between COVID-19 and other common respiratory diseases," Novacyt CEO Graham Mullis said.